

MDxHealth reports Q2 sales growth, mixed earnings and reaffirmed 2026 revenue guidance as tissue test volumes rise.
You can purchase shares of MDxHealth (NASDAQ:MDXH) through any online brokerage.
Other companies in MDxHealth’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MDxHealth has a consensus price target of $4.38.
The stock price for MDxHealth (NASDAQ: MDXH) is $0.16255 last updated November 9, 2026 at 11:29 AM EST.
There are no upcoming dividends for MDxHealth.
MDxHealth does not have any upcoming earnings scheduled.
There is no upcoming split for MDxHealth.
MDxHealth is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular...